Granulocyte colony-stimulating factor does not promote neurogenesis after experimental intracerebral haemorrhage

Int J Stroke. 2014 Aug;9(6):783-8. doi: 10.1111/ijs.12217. Epub 2013 Dec 19.

Abstract

Background: Hematopoietic growth factors have been suggested to induce neuroprotective and regenerative effects in various animal models of cerebral injury. However, the pathways involved remain widely unexplored.

Aims: This study aimed to investigate effects of local and systemic administration of granulocyte colony-stimulating factor on brain damage, functional recovery, and cerebral neurogenesis in an intracerebral haemorrhage whole blood injection model in rats.

Methods: Eight-week-old male Wistar rats (n = 100) underwent induction of striatal intracerebral haemorrhage by autologous whole blood injection or sham procedure and were randomly assigned to either (a) systemic treatment with granulocyte colony-stimulating factor (60 μg/kg) for five-days; (b) single intracerebral injection of granulocyte colony-stimulating factor (60 μg/kg) into the cavity; or (c) application of vehicle for five-days. Bromodeoxyuridine-labelling and immunohistochemistry were used to analyze proliferation and survival of newly born cells in the sub-ventricular zone and the hippocampal dentate gyrus. Moreover, functional deficits and lesion volume were assessed until day 42 after intracerebral haemorrhage.

Results: Differences in lesion size or hemispheric atrophy between granulocyte colony-stimulating factor-treated and control groups did not reach statistical significance. Neither systemic, nor local granulocyte colony-stimulating factor administration induced neurogenesis within the dentate gyrus or the sub-ventricular zone. The survival of newborn cells in these regions was prevented by intracerebral granulocyte colony-stimulating factor application. A subtle benefit in functional recovery at day 14 after intracerebral haemorrhage induction was observed after granulocyte colony-stimulating factor treatment.

Conclusion: There was a lack of neuroprotective or neuroregenerative effects of granulocyte colony-stimulating factor in the present rodent model of intracerebral haemorrhage. Conflicting results from functional outcome assessment require further research.

Keywords: acute stroke therapy; brain bleed; cerebral haemorrhage; neuroprotection; stem cells; stroke.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atrophy
  • Brain / drug effects
  • Brain / pathology
  • Brain / physiopathology
  • Bromodeoxyuridine
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Cerebral Hemorrhage / drug therapy*
  • Cerebral Hemorrhage / pathology
  • Cerebral Hemorrhage / physiopathology*
  • Disease Models, Animal
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Immunohistochemistry
  • Male
  • Neurogenesis / drug effects*
  • Neurogenesis / physiology
  • Neuroprotective Agents / administration & dosage*
  • Random Allocation
  • Rats, Wistar
  • Recovery of Function / drug effects

Substances

  • Neuroprotective Agents
  • Granulocyte Colony-Stimulating Factor
  • Bromodeoxyuridine